Trials / Recruiting
RecruitingNCT05710900
DiEt ChoIce to Promote Type 2 Diabetes REmission
DECIDE: DiEt ChoIce to Promote Type 2 Diabetes REmission Supported by Community Pharmacists and Registered Dietitians
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- University of British Columbia · Academic / Other
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Type 2 diabetes is typically viewed as a chronic, progressive, and lifelong condition. Patients and their healthcare providers "manage" type 2 diabetes through lifestyle modifications and various types of medications designed to lower blood sugar. Exciting new research indicates that "remission" of type 2 diabetes - defined as returning blood sugar into the normal range without having to use medications - through therapeutic nutrition may be possible for many people living with the condition. We will examine the preference, adherence and clinical results of a low-calorie diet or low-carbohydrate diet in type 2 diabetes remission rates.
Detailed description
Each dietary remission strategy involves three phases focused on weight loss and medication deprescribing (Phase 1: Weeks 0-12), transition to an individualized sustainable dietary pattern (Phase 2: Weeks 13-20), and weight loss/remission maintenance (Phase 3: Weeks 21-52). We will determine if there is a preference for one diet over the other, measure satisfaction with each approach, and determine clinical outcomes (T2D remission, medication use, blood biomarkers) at one year. Qualitative interviews and feedback surveys with the participants, pharmacists, and RD will provide information on barriers and facilitators to each T2D remission strategy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Dietary intervention | Each dietary remission strategy involves three phases focused on weight loss and medication deprescribing (Phase 1: Weeks 0-12), transition to an individualized sustainable dietary pattern (Phase 2: Weeks 13-20), and weight loss/remission maintenance (Phase 3: Weeks 21-52). |
Timeline
- Start date
- 2023-07-15
- Primary completion
- 2025-06-15
- Completion
- 2026-11-01
- First posted
- 2023-02-02
- Last updated
- 2025-03-07
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT05710900. Inclusion in this directory is not an endorsement.